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Elasticitya b s t r a c t
Elastin and collagen are the two main components of elastic tissues and provide the tissue with elasticity
and mechanical strength, respectively. Whereas collagen is adequately produced in vitro, production of
elastin in tissue-engineered constructs is often inadequate when engineering elastic tissues. Therefore,
elasticity has to be artificially introduced into tissue-engineered scaffolds. The elasticity of scaffold mate-
rials can be attributed to either natural sources, when native elastin or recombinant techniques are used
to provide natural polymers, or synthetic sources, when polymers are synthesized. While synthetic elas-
tomers often lack the biocompatibility needed for tissue engineering applications, the production of nat-
ural materials in adequate amounts or with proper mechanical strength remains a challenge. However,
combining natural and synthetic materials to create hybrid components could overcome these issues.
This review explains the synthesis, mechanical properties, and structure of native elastin as well as the
theories on how this extracellular matrix component provides elasticity in vivo. Furthermore, current
methods, ranging from proteins and synthetic polymers to hybrid structures that are being investigated
for providing elasticity to tissue engineering constructs, are comprehensively discussed.
Statement of Significance
Tissue engineered scaffolds are being developed as treatment options for malfunctioning tissues through-
out the body. It is essential that the scaffold is a close mimic of the native tissue with regards to both
mechanical and biological functionalities. Therefore, the production of elastic scaffolds is of key impor-
tance to fabricate tissue engineered scaffolds of the elastic tissues such as heart valves and blood vessels.
Combining naturally derived and synthetic materials to reach this goal proves to be an interesting area
where a highly tunable material that unites mechanical and biological functionalities can be obtained.
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Tissue engineering is a fast growing field that aims at generat-
ing functional constructs that mimic the structure and properties
of the extracellular matrix (ECM) of the native tissues. Although
many studies have been carried out in the field of tissue engineer-
ing, the number of constructs that are brought to the clinics is still
limited [1,2]. The limited clinical translation of engineered tissues
is mainly because many applications such as heart valve and blood
vessel replacements require the construct to be mechanically func-
tional upon implantation [3]. Thus, understanding the functional
mechanical properties of native tissues and how to mimic these
properties in an engineered construct is essential [4–7].
Native tissues consist of two major components: cells and the
ECM. The ECM consists of nonfibrous macromolecules such as gly-
cosaminoglycans (GAGs) and fibrous components such as elastin.
Although nonfibrous components are present in a relatively low
content in elastic tissues, they play an important role in the proper
mechanical functionality of these tissues [8]. In heart valves, for
example, the GAG-rich layer is able to absorb the shocks during
opening and closing of the valve [4]. Fibrous components, mostly
collagen and elastin, are the major elements that provide mechan-
ical functionality to elastic tissues. Collagen fibers provide strength
and structural support to the tissue. Elastin, however, provides
elasticity and is therefore mostly present in elastic tissues such
as lungs, heart valves, and blood vessels [2,9]. To engineer a tissue
in vitro, scaffolds are designed to provide initial mechanical stabil-
ity to the construct and to allow the cells to produce the proper
amount of the ECM with time. While the amount of collagen pro-
duced by the cultured cells is abundant, the amount of elastin is
limited [10–12]. Therefore, it is essential to artificially introduce
elasticity into the scaffold materials [13,14].
Elasticity can be tailored to the scaffold by using native elastin
derivatives [2] or synthetic elastomers [9]. While the use of native
elastin proves to be difficult owing to its large batch-to-batch vari-
ations [15], synthetic materials, which have a high tunability, may
cause problems regarding the biological functionalities, especially
by hindering cell adhesion [16]. Combining different natural and
synthetic materials with different functionalities, to form hybrid-
like structures, can address the limitations of both native elastin
and synthetic elastomers and thus offer a promising future
approach for the engineering of elastic tissues.
In this review, various elastic materials used for tissue engi-
neering applications are discussed. First, elastin synthesis, in vivo
procedure for fiber assembly, and occurrence of elastin in different
tissues are explained. Next, the current available elastic materialsfrom biological, recombinant, and synthetic sources for tissue engi-
neering purposes are discussed. Finally, hybrid materials, as




Cells produce elastin as the precursor tropoelastin before it is
transported outside the cells [17]. After alignment through coacer-
vation, the protein is crosslinked to form the mature elastin [18].
The majority of the elastin synthesis takes place in the late fetal
and early neonatal stage [11]. For humans, elastin production
starts between weeks 17 and 19 of pregnancy and continues into
early childhood before slowing down [14,19]. In line with this,
Johnson et al. indicated that aortic cultures from 1 to 3 day old
chickens showed a decreasing trend of elastin synthesis with time
[20]. They linked this decreasing trend to the half-life time of elas-
tin mRNA, which decreased from 25 h in 1 day old chickens to only
7 h in 8 week old chickens [20]. Because elastin has a half-life time
of approximately 70 years, during which it can go through billions
of extension and relaxation cycles without losing its function [2],
production and remodeling of elastin is not essential during adult-
hood except in the case of damage to the elastin fibers due to an
injury. The elastin fibers produced in the case of injury are disorga-
nized and therefore do not have mechanical functionalities same as
those of the elastin produced during early life [11]. Several exoge-
nous factors influence the production of elastin after injury, such as
tumor necrosis factor-a, interleukin 1b, insulin-like growth-factor-
1, and transforming growth factor [21].
The formation of mature elastic fibers, also known as elastoge-
nesis, starts with the translation of the elastin gene (ELN gene)
inside the cell nucleus and its transcription into tropoelastin in
the rough endoplasmic reticulum (RER) (Fig. 1A, I) [22]. The gene
coding for tropoelastin is a single coding gene that can have alter-
native splicing, thereby resulting in different isoforms of tropoe-
lastin [17]. In humans, the resulting tropoelastins possess a
weight of approximately 70 kDa [23] and consist of alternating
parts: a hydrophilic part containing predominantly alanine and
lysine, known as the crosslinking domain and a hydrophobic part
containing the repeating sequence of Val-Pro-Gly-Val-Gly
(Fig. 1B) [24].
Inside the cells, tropoelastin is bound to a chaperone, an elastin-
binding protein (EBP), that prevents intracellular coacervation.
Coacervation is a conformational reorganization of molecules in a
Fig. 1. A) Elastogenesis (adapted from Debelle and Tamburro [23] and Nivison-Smith and Weiss [22]): i) translation of the ELN gene, ii) transcription into tropoelastin and
association with EBP to prevent coacervation, iii) transportation of tropoelastin-EBP to the extracellular space by the Golgi apparatus, iv) interaction between EBP and GAS to
release tropoelastin, v) coacervation of tropoelastin guided by microfibrillin, and vi) crosslinking of tropoelastin into mature elastin by lysyl- oxidase. B) Chemical structure of
the repeating pentapeptide present in the hydrophobic part of tropoelastin. C) Chemical representation of the crosslink between tropoelastin moieties.
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(Fig. 1A, II) [25]. After secretion of tropoelastin by the Golgi appa-
ratus into the extracellular space, the EBP interacts with the
galacto-sugars (GAS), and this results in the release of tropoelastin
(Fig. 1A, III–IV). Coacervation is then guided by the microfibrils,
which are already present and play an important role in the align-
ment of the tropoelastin (Fig. 1A, V) [23,26]. After the tropoelastins
are aligned, the lysine moieties in the protein will be subsequently
deaminated and oxidized by lysyl oxidase in the presence of Cu2+
to form allysines and before crosslinking to form (iso)desmosine
(Fig. 1C) [18,23,27,28]. The crosslinking procedure leads to the for-
mation of mature insoluble elastin (Fig. 1A, VI) [2].
2.2. (Tropo)elastin properties
One of the important characteristics of tropoelastin is its coac-
ervation behavior, also known as lower critical solution tempera-
ture (LCST) behavior [25]. This behavior is vital in obtaining
properly aligned elastin fibers during elastin biosynthesis
(Fig. 1A, V). The purely entropic coacervation process occurs
because water is released from the chain, thus making itthermodynamically favorable for the polymers, proteins in this
case, to conformationally reorganize and aggregate [29]. The coac-
ervation temperature of materials is dependent on pH, salt concen-
tration, molecular structure, and concentration of the material. For
tropoelastin, coacervation occurs under physiological conditions,
as discussed in Section 2.1.
Within the cross-linked structures of mature elastin, the
tropoelastin moieties are quite flexible and show elastic behavior.
A good indicator for the elasticity of polymers at a certain temper-
ature is their glass transition temperature (Tg). The polymer is in a
rubbery state with more elasticity above the Tg, whereas it is usu-
ally brittle in the glassy state below the Tg. The Tg of dry elastin is
approximately 200 C, but upon increasing the hydration to 30%,
the Tg significantly decreases to only 30 C, thus indicating that
elastin shows elastic behavior only in its hydrated state [2].
The necessity of water for elasticity implies that water plays an
important role for conferring elasticity [30]. One theory states that
when elastin swells in water, water molecules distribute through
the elastin network. In this case, interaction of water molecules
with the polar peptide groups mediates macromolecular
conformational and translational segmental motion, thus making
A.M.J. Coenen et al. / Acta Biomaterialia 79 (2018) 60–82 63the network more flexible [23]. In the relaxed state, water inside
the elastin network interacts strongly with the bulk water sur-
rounding the network. When the network is extended, the bulk
water is excluded and accounts for a loss in entropy. The influence
of water, owing to its plasticizing effect, can also be explained by
the large amount of b-turns found in elastin. The sliding behavior
of one residue in these b-turns toward the C-terminus leads to
intrinsic entropy owing to its dynamic nature [23].
Different theories about the exceptional mechanism of elastic-
ity in elastin are based on the structure of the hydrophobic
domains. One theory, based on enthalpic forces, states that when
the protein is extended, the hydrophobic side chains of elastin
are exposed on the outside. Consequently, the overall energy in
the system increases enthalpically, thus supporting the conven-
tional entropic diving force to recoil [14]. It is important to note
that all described theories on the elasticity mechanisms in elastin
indicate that the relaxed state is more hydrated, more chaotic or
unstructured, and more mobile than the extended state.
The Young’s modulus is an indication for the stiffness of mate-
rials and is derived by generating the stress–strain curve. Young’s
moduli of elastin reported in the literature differ substantially.
For example, a study on aortic elastin fibers purified by autoclaving
and measured in a water bath (a hydrated environment) showed a
Young’s modulus of 0.81 MPa and a maximum extension of
approximately 100% [31]. However, purified single elastin fibers
from ligaments showed a Young’s modulus of 1–1.2 MPa and an
extension of 100–200%; the results were dependent on the purifi-
cation method [32–34]. Other sources, on the other hand, reported
a much lower Young’s modulus of 300–600 kPa with similar exten-
sions of 100–220% [14,35]. An explanation of the discrepancy
between Young’s moduli can be related to the differences in the
source of elastin as well as the measurement conditions. Because
elastin has a viscoelastic nature, the mechanical response is time
and temperature dependent, meaning that the strain rate could
influence the resulting value. Furthermore, environmental condi-
tions such as relative humidity could also influence the outcome
of mechanical tests [36]. The above-mentioned parameters shouldFig. 2. Stress–strain curves of cyclic compression tests on a cartilage tissue showing the h
can be seen, the energy dissipation reduced with increase in the number of cycles. Furt
Reprinted from Fazaeli et. al. [38], with permission from Elsevier, copyright 2016. (For int
the web version of this article.)be considered for a proper comparison of the results of different
studies.
For elastic tissue engineering applications, the toughness of the
material is not the only important mechanical characteristic, as it
does not prove the reversible extensibility, which is known as elas-
ticity. Therefore, it is important to generate the repetitive stress–
strain curves. In biological tissues, the curves generated consist
of not one but two successive regions, which allow the material
to return to its original state under larger strain. The first part of
the curve, called the toe region, represents the phase where the
undulated collagen fibers are stretched to an extended state, and
the second part represents the phase where uncrimped collagen
fibers are stretched. Recruitment pattern and alignment of collagen
fibers, when the tissue is extended, primarily define the trend of
such curves. Finally, the shape of the curves is dependent on the
relative quantitative proportion, three-dimensional arrangement,
and the mechanical properties of collagen and elastic fibers [37].
Fig. 2 shows an example of a cyclic stress–strain curve for a car-
tilage tissue, wherein there is a large dissipation of energy due to
hysteresis in the first few cycles [38]. However, with time, the hys-
teresis curves almost overlapped. Furthermore, when collagen was
removed from the tissue, the tissue showed a mechanical behavior
more similar to that of elastin and experienced significantly less
stress for the same strain as well as a low dissipation of energy.
This elastic behavior under large strains is the main point of focus
for the discussion of elasticity in this review.
2.3. Occurrence of elastin in different tissues
Different types of tissues have different mechanical property
requirements; some tissues have to be elastic, whereas other tis-
sues have to be stiffer. Therefore, the content and structure of elas-
tin vary within different native tissues. The highest amounts of
elastin obtained from the tissue dry weight can be found in elastic
ligaments (70%) [2] and large arteries (50%) [2], and the lowest
amounts of elastin can be found in the lungs (30%) [2], heart valves
(10–15%) [39], skin (2–5%) [40,41], cartilage (1–20%) [42–44], theysteresis loops of a control tissue (black) and a tissue without collagen (orange). As
hermore, removal of collagen led to a lower stress response under the same strain.
erpretation of the references to colour in this figure legend, the reader is referred to
Fig. 3. Visualization of elastin (green) and collagen fibers (blue) showed different structures of elastin for different tissues. A) Articular cartilage from equine
metacarpophalangeal joint. B) Intervertebral disc from equine tail. C) Adipose tissue from the human omentum (cells are stained in red). D) Small resistance arteries and veins
from human abdominal subcutis. E) Chordae tendinae from porcine heart. F) Porcine aorta. Reprinted from Green et al. [37], with permission from the Royal Society, copyright
2014. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
64 A.M.J. Coenen et al. / Acta Biomaterialia 79 (2018) 60–82chordae tendineae (2–5%) [45,46], and the intervertebral disc (2%)
[47,48], mostly in the nucleus pulposus [37].
Native tissues also differ in the three-dimensional (3D) struc-
ture of elastin (Fig. 3). The arrangement of elastin fibers has a
tremendous effect on the mechanical behavior of the tissue. In liga-
ments, arteries, and the skin, elastin mostly forms rope-like struc-
tures [2,41], which is then organized in different manners. In
ligaments, the fibers show parallel orientations [2] and provide
the tissue stress-bearing properties. In elastic arteries such as the
aorta, the elastin fibers form concentric lamellae including thick
internal and external elastic laminae. This lamellar structureallows the arteries to comply with changes in blood pressure and
hemodynamic stresses during the cardiac systole and diastole
[49]. On the other hand, in muscular arteries such as femoral arter-
ies, elastin fibers do not form lamellar units [50]. It should be noted
that the structure and the amount of elastin in different types of
blood vessels depend on their location in the circulatory system
because their mechanical properties should match with the local
hemodynamic conditions. For example, a comparison between
the structure of elastin in cremaster muscle arterioles, which are
physiologically subjected to longitudinal stretch, and in cerebral
arteries, which are not exposed to longitudinal stretch, revealed
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arterioles were absent in cerebral arteries [51].
The structure of elastin in the cartilage remained unclear for a
long time, as elastin was not considered as a crucial component
of the ECM owing to its low amount. However, low amounts of
elastin can have a large impact on the mechanical properties of
the tissue. A study on the articular cartilage showed several
microstructures to be present. A fine and dense network of elastin
fibers could be found around the chondrocytes. This niche of elas-
tin seems to protect the chondrocytes, as they only experience
mild stretching forces even when the cartilage is subjected to rel-
atively larger forces [52]. At the superficial layer, a cobweb-like
elastin fiber network could be found. Because it is known that ten-
sile strains are predominantly applied on the surface, the elastin
present in this layer could increase the resistance of the cartilage
to strain in different directions [52].
Furthermore, in the intervertebral disc, the elastin fibers are
organized randomly in their relaxed state. When load is applied,
elastin fibers located between the lamellae of collagen fibers form
a more organized structure in the extended state than the relaxed
state. Herein, the elastin fibers play a role in recoiling the tissue by
returning and crimping the collagen fibers to their original pre-
loaded state [57]. Even in low amounts, elastin has an impact on
the mechanical properties of the total tissue, particularly by recoil-
ing the collagen fibers after deformation, as observed in the skin
[58].
One of the most complex alignments of elastin fibers can be
found in heart valves. Heart valves can be divided into three layers,
and the elastin fibers are organized differently in each layer. In the
fibrosa, elastin forms tubular structures and the fibers are aligned
in the circumferential direction [53]. The elastin content in the
fibrosa is relatively low, and it is hypothesized that these tubular
structures most likely contribute to the stress-tolerance properties
of the tissue. However, elastin-rich ventricularis shows elastin
fibers arranged in sheets. This structure leads to an extension toTable 1
List of available elastomeric scaffolds from natural materials for tissue engineering applic
Category Material Material properties
Decellularized
tissue
Decellularized bovine arteries [59] Strain at break Axial = 15
Circumferential = 50%
Burst strength = 1300 MPa
Decellularized lungs [66,67] –
Decellularized bladder [68] –
Decellularized bovine cornea [69] Ultimate tensile
strength = 3.5 MPa
Tissue extensibility = 6.6
Native elastin Purified elastin fibers [60] –
Insoluble elastin–collagen [72] E (wet) = 3 MPa
Yield strain = 45%
Yield stress = 0.25 MPa
Soluble elastin-collagen [72] E (wet) = 2 MPa
Yield strain = 50%
Yield stress = 0.15 MPa
Electrospun a-elastin [74] Tensile strength = 1.6 MPa
Ultimate elongation = 0.01up to 60%, which is quite remarkable because collagen is almost
inextensible [54]. In the spongiosa, elastin fibers have a sponge-
like structure [55]. As the spongiosa functions like a buffer
between the ventricularis and the fibrosa, the organization of elas-
tin is to aid this function.
As indicated in the previous section, depending on whether col-
lagen or elastin is the major component of the ECM, the mechanical
behaviors of the tissue significantly differ. Thus, when designing a
scaffold for a tissue engineering application, it is crucial to define
the benchmarks in terms of the amount and particularly the struc-
ture of the ECM components, which finally define the mechanical
properties of the construct. For example, different layers of the
heart valve possess different mechanical properties owing to the
different structures and amounts of elastin present in each layer.
Consequently, the fracture tension of the elastin fibers in the cir-
cumferential and radial directions, respectively, was 0.35 and
0.14 Nm1 for the fibrosa and 2.94 and 2.81 Nm-1 for the ventricu-
laris [56]. The structure of elastin and collagen fibers also defines
the morphology and alignment of the cells through the contact
guidance mechanism, which then influences the alignment of the
ECM deposited by the cells.3. Elastic materials for tissue engineering
As discussed earlier, the elasticity prevailing across numerous
deformation cycles of tissue-engineered scaffolds is of importance
for the proper functioning of the implants in vivo. Because the pro-
duction of elastin by cells in vitro is limited, elasticity has to be
introduced into the scaffold material. This section provides an
overview of the sources that can be used to gain elastic materials.
Additionally, a summary of the mechanical properties of natural
materials (Table 1), recombinant materials (Table 2), and synthetic
materials (Table 3) and a description of the state of the research for




Native architecture was maintained; human
saphenous vein endothelial cells adhered to
the matrix and formed a monolayer
Lung transplantation Mechanical functionality similar to that of
native lungs. Participation in gas exchange was
observed in short-term in vivo studies (45–
120 min)
Bladder regeneration Long-term in vivo studies (22 weeks) showed
limited cellular repopulation in the middle of
the scaffold. After 22 weeks, no difference was
observed in the rupture stress, but a significant
decrease was shown for rupture strain. The
tissue modulus increased as well
Cornea regeneration No significant difference in ultimate tensile
strength compared to the native tissue. In vivo
studies showed good biocompatibility
Tissue engineering Pure and intact elastin fibers showed a
significantly lower cell response than partially
purified fibers or partially degraded fibers after
in vivo implantation, which is probably caused
by a lower inflammatory response
Vascular grafts Decrease in Young’s modulus and yield strain
after elastin incorporation into the collagen
scaffold as well as an increase in the mature
smooth muscle cell fraction
Vascular grafts Decrease in Young’s modulus and yield strain
after elastin incorporation into the collagen
scaffold as well as an increase in the mature
smooth muscle cell fraction
Tissue engineering Scaffold could support the attachment and
growth of human embryonic palatal
mesenchymal cells during in vitro studies
Table 2
List of available elastomeric scaffolds from recombinant techniques for tissue engineering applications (E = Young’s modulus).
Category Material Material properties Application Major outcome
Tropoelastin Cross-linked tropoelastin
hydrogel [81]
E = 220–280 kPa
Elastic until strain reaches 150%
Elongation at break = 200–370%
Tissue engineering Highly extensible gels with elastic behavior
up to 150% elongation. In vitro studies
showed both growth and proliferation,
whereas in vivo studies showed that the
scaffolds were well tolerated
Tropoelastin-silk [82] – Nerve guidance The growth of both peripheral neurons and
Schwann cells was supported by the scaffold
Elastin-like
polypeptides
ELP-solution [88] Shear modulus = 0.15–0.50 Pa Cartilaginous tissue
repair
A threefold increase in shear modulus of the
ELP solution at above compared to below the
transition temperature. In vitro cell studies
showed that chondrocytes maintained their
phenotype
In situ cross-linked ELP [90] Shear modulus = 0.26 kPa Cartilaginous tissue
repair
Mechanical integrity increased in vivo, thus
suggesting that the original matrix is




E = 1.2–2.2 kPa
Ultimate tensile strength = 6.5–10 kPa
Extensibility = 3.5–4
Compressive modulus = 3–15 kPa




Mechanical properties could be tuned by
changing the concentration. After
subcutaneous implantation, long-term
structural stability was observed
Cross-linked ELP gel [92] E = 0.10–0.32 MPa
Shear modulus = 0.04–0.12 MPa
Elongation at break = 250–400%
Vascular tissue
engineering
Mechanical tests under physiological
conditions showed dependence on the cross-
linking density
Table 3
List of available synthetic elastomeric scaffolds for tissue engineering applications (E = Young’s modulus).
Material Material properties Application Major outcome Chemical structure
PGS tubes [102] – Nerve guidance Compared to currently used
PLGA scaffolds, less
inflammation and fibrosis












E = 1.66 MPa
Strain at break = 113%















Porous PGS [105,107] Effective
stiffness = 0.83 MPa
Skin and heart valve
regeneration
Scaffolds for heart valves
showed similar mechanical
properties compared to
bovine aortic heart valves.

















Bone tissue engineering Tunable and promising
material properties for bone
engineering. In vivo studies
showed good











PCL-based PU [114] Compression
modulus = 22.6 kPa (with
cells)
Cartilage tissue engineering Cell attachment and cell
proliferation were observed.
However, dedifferentiation
of chondrocytes and the
diffusion of significant
amounts of ECM into the
media were also observed
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Table 3 (continued)
Material Material properties Application Major outcome Chemical structure
Poly(ester urethane) based
on PCL [115]
E = 10 MPa
Ultimate tensile
stress = 3.3 MPa





























PHA-PLA-PGS [123] – Myocardial tissue
engineering
Mesenchymal stem cells
were properly aligned on
the scaffolds and were able



















P4HB-GelMA [124] E = 5.68 MPa
Ultimate tensile
stress = 2.68 MPa
Pulmonary arterial patch A functional arterial patch
capable of withstanding the
physiological conditions







PHB [125,189] – Nerve regeneration In vivo transplantation of




PHBHHx [121] – Nerve conduit and
cardiovascular regeneration
Less platelet adhesion
compared to PHB films. In
vivo studies for nerve
conduits showed PHBHHx
to be highly compatible; it
was also able to form a








PCL springs [129] Strain at break = 260% Cardiac tissue regeneration Spring-like fibers showed a
stronger contraction force
and a higher beating rate
















POC-PLLA [110] Tensile strength = 1.51 MPa
Young’s
modulus = 17.73 MPa
Elongation at break = 182%
Permanent deformation




functionalities suitable for a
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Obtaining elastin from the natural ECM that can be used for tis-
sue engineering applications is highly challenging. Different forms
of elastin that can be obtained from animal sources are tissues con-
taining elastin [59], purified elastin fibers [60], hydrolyzed elastin
[61], and tropoelastin [62]. Decellularized tissues are a natural
elastic matrix in which the cells have been carefully removed to
avoid an immunogenic reaction [63]. The tissue can then be either
reseeded with cells and cultured before in vivo application (Fig. 4A)
or implanted as an acellular construct [64]. The most important
advantage of the decellularization technique is that the ECM struc-
ture of the original tissue is preserved. However, as tuning of the
elastin properties can be done, the application by this method islimited because other ECM components are still present, which
will prohibit the use of a particular tissue for another tissue
replacement.
In one study, decellularizing bovine arteries and subsequent
in vitro cell reseeding led to the high cell viability in vitro, and acel-
lular scaffolds had a significantly lower rejection response in vivo
than the untreated tissues [65]. Furthermore, mechanical testing
of the decellularized tissues confirmed that the mechanical
strength was preserved during the decellularization process [59].
Decellularized lungs have also shown to be viable both in vitro
and in vivo [66,67]. Furthermore, decellularized tissues from the
bladder [68] and the cornea [69] have been successfully tested
for tissue engineering applications. Although these results show a
potential for using decellularized scaffolds, the process to obtain
Fig. 4. A) A schematic representation of decellularization procedure of a tissue engineered lung. First, cannulas were made in the lung at the pulmonary artery, and the
trachea was filled with decellularization solutions. After 2–3 h, the decellularized tissue was obtained, which is then seeded with pulmonary vascular endothelium using a
biomimetic bioreactor. After 4–8 days, the tissue engineered lung was ready for implantation. Reprinted from Petersen et. al. [66], with permission from AAAS, copyright
2010. B) Verhoeff-Van Gieson histochemical staining of elastin in native (I) and decellularized (II) tissues showed structural disruption of the fibers. C) Scanning electron
microscope images of the cross-section of blood vessels before (I) and after (II) decellularization. Fibers appeared to be rough, and the gap between fibers increased upon
decellularization. Reprinted from Gong et. al. [71] with permission from Elsevier, copyright 2016.
68 A.M.J. Coenen et al. / Acta Biomaterialia 79 (2018) 60–82decellularized tissue changes according to the type of tissue. Fur-
thermore, the use of chemicals and enzymes, in some cases, can
influence the mechanical properties of the resulting scaffolds as
can be seen in Fig. 4B and 4C. In Fig. 4B, the Verhoeff-Van Gieson
staining method was used to stain the native (Fig. 4B, I) and decel-
lularized (Fig. 4B, II) tissues for elastic fibers. As shown in the fig-
ure, the structure of the native tissue is disrupted because of
decellularization. In addition, in Fig. 4C, scanning electron micro-
scope images of blood vessels in the native (Fig. 4C, I) and decellu-
larized (Fig. 4C, II) tissues show a large distance between the fibers
upon decellularization. In Fig. 4C, II, it can be seen that the fibers
are disconnected [2,22,70,71]. It should be noted that there is a
compromise between removal of all cellular material and preserva-
tion of the ECM structure. The feasibility of current decellulariza-
tion protocols depends on the acceptability of this balance for
each application.
Pure elastin fibers can also be obtained from animal sources.
Mature elastin, however, is highly insoluble because it is cross-
linked, thus making purification and processing of elastin chal-
lenging. The main drawback of elastin purification is that it
often damages the fibers, especially if all remnants of microfibril-
lar components are removed. However, Daamen et al. optimized
the protocol to obtain pure intact elastin fibers [60]. Purified elas-
tin can be fabricated to scaffolds with different structures depend-
ing on the target application. However, the structure of
decellularized tissues cannot be modified for different target tis-
sues. Incorporation of insoluble elastin into electrochemically
aligned collagen (ELAC) fibers led to a decrease in yield stress
and Young’s modulus (from 10 to 2 MPa) both before and after
culturing with smooth muscle cells, whereas the yield strain wascomparable, thus showing the influence of elastin incorporation
on mechanical properties [72]. In the same study, soluble elastin,
prepared by oxalic acid treatment, was incorporated into ELAC
fibers, and the resulting mechanical properties were similar to
those of insoluble elastin [72]. It should be mentioned that solubi-
lizing the elastin through hydrolyzation of the peptide chains
increases the processability.
Hydrolyzation of elastin by different agents results in different
elastin fragments. For example, hydrolyzation of elastin by oxalic
acid treatment resulted in two different fractions: a-elastin
(60 kDa), which shows the typical reversible coacervation behav-
ior, and b-elastin (5 kD), which is present in the supernatant at all
temperatures [2,61]. Moreover, j-elastin (70 kDa) is obtained by
hydrolysis with potassium hydroxide [2,14,73]. Different methods
based on enzymes can also be employed to obtain soluble elastin,
but the resulting elastin fragments differ according to the enzyme
used [2,14]. Electrospinning of a-elastin led to brittle scaffolds;
however, these tests were performed under dry conditions
wherein elastin does not exhibit elastic behavior. Furthermore,
the scaffold could not support cell attachment, migration, and pro-
liferation [74]. This result is counterintuitive with the advantage of
natural materials, which usually provide a better biological
response than synthetic materials. It is possible that solubilization
reduces the biological response. Furthermore, the absence of other
ECM components could be the reason that cell studies did not yield
desirable results. Although soluble elastins are better to process,
hydrolyzation compromises the mechanical properties of the
resulting peptides. Additionally, results depend on both the source
of elastin and the method used, therefore influencing the
reproducibility.
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mals when harvested during the late fetal or early neonatal stage
[62]. In this stage, crosslinking is prevented because copper is an
essential cofactor for the crosslinking enzyme lysyl oxidase [75].
However, the single tropoelastin moieties are prone to degradation
by proteases because of free amine moieties [76]. If tropoelastin
extraction is successful, then it results in molecules with various
molecular weights [77]. All the above-described methods have the
disadvantage of using animals as a source, thus leading large
batch-to-batch variations and also difficult processability ofmateri-
als. Furthermore, tuning of such materials and thus their properties
is limited. Therefore, materials with easy processability and tunable
chemical and mechanical properties are favorable for application.
3.2. Elastin production by recombinant techniques
Recombinant techniques, mostly using bacteria, provide con-
trollable and well-defined results for protein synthesis. The first
report on the expression of the complete tropoelastin molecule
in a bacterial system (Escherichia coli) was published in 1990
[78]. The tropoelastin molecule produced by recombinant tech-
niques is obtained as single strands. Further processing of this
tropoelastin molecule with lysyl oxidase yields insoluble elastin,
even in the absence of other macromolecules. However, the loca-
tion of the crosslinks between the synthetic elastin molecules
and the alignment of the synthetic elastin fibers will not be same
as those in native mature elastin without the guidance of the other
macromolecules [79]. Further investigation showed that recombi-
nant tropoelastin could be incorporated into the ECM by non-
elastogenic rat-1 fibroblasts that express lysyl oxidase [80].
Tropoelastin can be used for many tissue engineering applica-
tions; for example, it can be used as a chemically cross-linked
hydrogel [81]. The scaffold produced this way had a Young’s mod-
ulus of 220–280 kPa and showed elastic behavior until an exten-
sion of 150%, with the final extension at a break of 200–370%
[81], thereby making it an interesting material for tissue engineer-
ing of elastic tissues. Moreover, blending of tropoelastin and silk
produced a material that improved cell growth and was used for
nerve guidance [82]. Tropoelastin has recently been used in many
studies because it not only can serve as an elastic component with
biological recognition in the scaffold material but also is a potential
elastogenic molecule that can stimulate the synthesis of elastin.
By changing the genetic code on the vector incorporated in the
bacteria, proteins that are different from those available in nature
can be produced, which remarkably increases the possibilities. For
example, a polypentapeptide, (VPGVG)n, derived from the repeat-
ing pentapeptide in elastin was synthesized in bacteria in 1974
[83]. Interestingly, this polypentapeptide showed coacervation
behavior in region same as that of a-elastin obtained from the
pig aorta [83]. Inspired by these results, more changes were made
in the amino acid sequence, thus leading to elastin-like polypep-
tides (ELPs). The amino acid sequence of the ELPs was on the basis
of the sequence VPGXG, where X is any amino acid except proline
[84]. These ELPs also showed coacervation behavior upon increas-
ing the temperature. The transition temperature of these ELP solu-
tions could be influenced by the length of the peptides, the amino
acid residues at position X, and external stimuli such as salt con-
centration and pH [85,86]. Furthermore, these ELPs have been
shown to be highly biocompatible [87], therefore making it an
interesting candidate for tissue-engineered scaffolds.
Several successful scaffolds based on the ELPs were made for
engineering cartilage tissues. One is the ELP solution with vis-
coelastic properties, which was proposed to be used as an inject-
able scaffold in the future [88]. However, this is based on single
strands of the ELP that cannot withstand the load applied to the
cartilage in vivo. In situ cross-linking of ELP gels yielded positiveresults to overcome this in a goat osteochondral defect model
[89]. The crosslinking increased the dynamic shear stiffness of
the material from 0.08 to 0.26 kPa, and after culturing with cells
for 6 days, the stiffness further increased to 1.7 kPa [90].
ELP hydrogels could be modified to be photo cross-linked. Cys-
teine moieties introduced at both the C- and the N-terminus of the
peptides can be cross-linked using a photoinitiator and a reducing
agent [91]. The photo cross-linkable hydrogels showed good
mechanical properties [91]. Fig. 5A shows high extensibility of
the 10% w/v ELP hydrogel up to 310%, and Fig. 5B shows the
stress–strain curves of this material under cyclic compression, thus
showing the elasticity of the material. Furthermore, in vivo testing
showed early ingrowth of the noninflammatory tissue into the ELP
gel, showing biocompatibility and integration of the ELP hydrogel
(Fig. 5C). These functionalities make the ELP hydrogel particularly
promising to be used as a sealant for soft tissue injuries [91]. Dif-
ferent cross-linked ELP gels with Young’s moduli of 100–300 kPa
have also been investigated for vascular graft applications [92,93].
3.3. Synthetic elastomers
A completely different approach is using synthetic elastomers
in tissue engineering applications. These materials have no struc-
tural link to elastin but can still exhibit the same mechanical func-
tionality. Scaffolds based on synthetic elastomers have the
advantage that they can be easily modified at both small and large
scales [9] by either chemical alteration of the polymeric chain, for
example, by changing the monomer [94], or by postmodifications,
for example, by crosslinking [95]. Furthermore, they can be molded
into virtually any shape and size [96]. Therefore, synthetic elas-
tomers are widely investigated for tissue engineering applications.
Although many synthetic elastomers show potential characteris-
tics for tissue engineering applications [96], they have not all been
tested for their feasibility with regard to this. Herein, only the syn-
thetic elastomers that have already been investigated for tissue
engineering purposes are discussed. This review does not include
polymers that are not classified as elastomers, such as poly(lactic
acid) (PLA) [97–99] or poly(ethylene glycol) (PEG) [100,101].
Poly(glycerol-co-sebacate) (PGS) is a polyester elastomer inves-
tigated for a range of different applications within the field of tis-
sue engineering. Tubes made of PGS are excellent candidates for
biodegradable peripheral nerve repair, especially because they do
not swell in water [96,102,103]. A scaffold can be prepared for
retina regeneration by processing PGS so that it forms microfabri-
cated layers on which retinal progenitor cells can be seeded [104].
Furthermore, porous PGS scaffolds, processed by laser ablation,
could mimic the peak tangent moduli (maximum slope of the
stress–strain curve) of bovine aortic heart valves in both circumfer-
ential (PGS scaffold, 0.83 MPa; Native heart valve, 1.00 MPa) and
radial directions (PGS scaffold, 0.21 MPa; Native heart valve,
0.26 MPa) [105].
Recent studies have also indicated that PGS in combination with
nanosilicates is a promising candidate for bone tissue engineering
[106]. The combination of elasticity and tunable stiffness was par-
ticularly favorable to provide the scaffold the ability to withstand
the loading and influence the regeneration of the bone. Further-
more, the nanosilicates enhanced the growth rate of bone cells.
The porous structure of the scaffolds became more rough with an
increasing amount of nanosilicates (Fig. 6A), which might enhance
cell adhesion and spreading [106]. The biocompatibility was tested
in vivo in mice, the results showed infiltration of cells into the scaf-
fold after 3 and 6 days (Fig. 6B). Moreover, different porous scaf-
folds made of PGS and fabricated through leaching techniques
have been used for skin regeneration [107]. Although PGS scaffolds
show favorable mechanical functionalities, they lack motifs to
stimulate cell adhesion. Thus, surface modification techniques
Fig. 5. Highly elastic cross-linked ELP hydrogels. A) Photographs of the ELP hydrogel under 0% (left), 260% (middle), and 310% (right) strain. B) Cyclic loading and unloading of
the hydrogels under compression tests. C) In vivo tests showed early integration of the ELP hydrogel by non-inflammatory tissue. Reprinted from Zhang et. al. [91] with
permission from John Wiley and Sons, copyright 2015.
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example, in this case, an RGD motif was introduced onto a PGS
polymer, which is known to promote cell adhesion.
A different type of polyester elastomers is poly(diol citrate).
Poly(1,8-octanediol-co-citrate) (POC) is often used for tissue engi-
neering purposes. POC-based films were compared with hemo-
compatible FDA-approved materials to evaluate their feasibility
for vascular tissue engineering. Hemocompatibility tests showed
low attachment of platelets and low protein binding and that the
endothelial cells retained their morphology under flow conditions,
thus showing encouraging results [109]. POC was also mixed with
a poly(L-lactic acid) (PLLA) nanofiber network to provide reinforce-
ment to the scaffold. Mechanical properties of these scaffolds were
analyzed, and the material was hypothesized to be feasible for use
for ligament, vascular, and cartilage tissue engineering; however,
neither in vitro nor in vivo testing has been carried out yet [110].
Another class of synthetic elastomers is polyurethanes (PUs).
This large class of elastomers varies in chemical structure, mechan-
ical functionality, and also degradation profile and has therefore
often been studied for various tissue engineering applications
[111,112]. A PU based on lactic acid urethane and maleate was
investigated for bone tissue engineering as load-bearing bone fil-
lers [113]. Young’s moduli of this PU material were measured
under compression, tension, bending, and torsion. The results
showed similar or even better mechanical properties than previ-
ously designed bone fillers. Furthermore, cell seeding with human
bone marrow and endothelial cells showed rapid cell attachmentand high biocompatibility with both cell types [113]. However,
these materials are not as strong as native bone and can therefore
only be used in a period of recovery in combination with fixation of
the bone and minimized physical load.
Different PUs have also been investigated for cartilage tissue
regeneration [114]. Attachment of chondrocytes to these scaffolds,
as well as their growth and differentiation, was supported to up to
42 days in vitro [114]. In addition, production of ECM components
was observed. However, dedifferentiation occurred after prolonged
culturing. The authors proposed that mechanical loading might
prevent dedifferentiation of the cells and trigger the formation of
a functional cartilage mimic. Cardiac patches for myocardial tissue
engineering have also been fabricated using PUs [115]. In this case,
a bilayer scaffold based on a poly(ester urethane) synthesized with
poly(e-caprolactone) (PCL) diol, 1,4-butanediisocyanate, and L-
lysine ethyl ester dihydrochloride was fabricated. The mechanical
functionality tests showed a Young’s modulus of approximately
10 MPa with an ultimate tensile stress of 33 MPa. Cyclic tensile
tests were performed to up to 10% deformation, where the stress
response increased only 3.1% across the cycles, and the material
showed elastic behavior in that region [115]. Other applications
for PU-based scaffolds are in the fields of nerve regeneration
[112] and heart valve tissue engineering [9]. Not only the potential
applications of PUs in tissue engineering were investigated, contin-
ued research has also been conducted in inventing new ways to
design scaffolds [116,117] and in understanding and tuning the
degradation of these scaffolds [111,118].
Fig. 6. A) Histological analysis showed cell infiltration into the scaffold after 3–6 days of implantation. Scaffolds were implanted between the quadriceps and the femur bone
in mice. B) General overview of the porous structure of PGS-nanosilicate materials with detailed representation of the lateral/exterior region and the lateral/transverse cross-
section. Reprinted from Kerativitayanan et. al. [106], with permission from ACS publications, Copyright 2017. C) An example of the PGS polymer functionalized with PEG-Gly-
Arg-Gly-Asp-Ser(GRGDS) modification to enhance cell adhesion. Reprinted from Ilagan and Amsden [108], with permission from Elsevier, copyright 2009.
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noate)s (PHAs) can have an elastic nature; for example, medium-
chain length PHAs show elastic behavior [119] and have therefore
been used in a range of biomedical applications [120]. Poly(4-
hydroxybutyrate) (P4HB) is a type of PHA used in cardiovascular
applications. The degradation of pure P4HB is quite fast [121], thus
making it unfavorable for cardiovascular applications that usually
need longer mechanical functionality of the scaffold. However,
P4HB can be used for coating scaffolds such as poly(glycolic acid)
to provide initial mechanical integrity before the cells produce
their own ECM [122]. It has been shown that by electrospinning
a blend of a type of PHA with poly(L-D,L-lactic acid) and PGS, a thick
myocardial patch could be produced [123].
Recently, a combination of P4HB and methacrylated gelatin
(GelMA) resulted in a scaffold that was successfully implanted asa pulmonary arterial patch [124]. In this case, the fibrous structure
of P4HB was surrounded by a hydrogel made of photo cross-
linkable methacrylated gelatin. This patch was implanted into a
sheep model where it showed no thrombogenicity and could with-
stand the physiological loading conditions. Furthermore, within
cylindrical scaffolds of poly(3-hydroxybutyrate) (PHB), nerve
regeneration was observed within 1 month in both myelinated
axons and Schwann cells [125]. A more recently developed PHA,
called poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBHHx)
[121], was found to be less brittle and showed better biocompatibil-
ity than the previously reported PHA polymers. Applications of this
polymer in tissue engineering are quite broad owing to the tunable
mechanical properties. Thus far, its use has been reported for bone,
cartilage, nerve, brain, smooth muscle, and soft tissue engineering
[126,127].
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neering applications is PCL [128]. For example, PCL was used to
mimic the 3D structure of cardiac tissues by synthesizing spring-
like PCL fibers by changing the speed of electrospinning from
7 ml/h for straight fiber to 0.5 ml/h for spring-like fibers [129].
The rationale behind producing spring-like PCL fibers comes from
the structure of native cardiac tissues, where straightening and
recoiling of these fibers make the muscles contract in the direction
of the cardiomyocytes [130]. These spring-like fibers were com-
pared with the straight PCL fibers in a test with single cardiomy-
ocytes, and it was shown that the contractions of cardiomyocytes
could not contract the straight fibers but could move the spring-
like fibers in a repetitive manner. The spring-like fibers showed a
lower Young’s modulus and a higher strain at failure than the
straight ones. Well-defined structures with a range of mechanical
properties can be produced using PCL, thus increasing its potential
for tissue engineering applications [131].
For many tissue engineering applications, combinations of dif-
ferent materials are made to obtain the proper mechanical func-
tionalities necessary to create a particular functional tissue. In
the cases explained thus far, noncovalent mixtures of materials
have been used. However, improvement in the mechanical and
biological properties can also be made by using covalent links
between different materials such as two different proteins or pro-
tein derivatives, two synthetic polymers, or a combination of these
two classes. The possibilities of these material combinations in the
field of tissue engineering are reviewed in the next section.4. Elastic hybrid materials for tissue engineering
The rationale behind preparing hybrid materials instead of
using single-component materials is to combine the positive func-
tionalities of each material to create a construct that has better
overall properties such as mechanical functionality, biocompatibil-
ity, and (bio)degradability. For example, materials with good
mechanical properties that lack motifs for cell attachment or pro-
liferation could be combined with proteins or polymers that can
enhance these properties. Such combinations lead to a material
with easier processability and smaller batch-to-batch variations
than a material containing only proteins for instance. Examples
of the materials with the above-mentioned enhanced properties
can be found in the following sections. Although these advantages
can lead to the use of better performing materials for tissue engi-
neering constructs, synthesizing hybrid materials can be highly
challenging, especially when different fabrication techniques have
to be employed. Therefore, a balance between the complexity of
the production and fabrication processes and the benefits present
in hybrid materials has to be maintained.
In this section, hybrid materials are classified into three differ-
ent categories, namely, polymer–polymer, protein–protein, and
polymer–protein hybrids. Notably, hybrid materials are considered
to have a covalent crosslink between their different components. In
addition, an overview of the synthetic polymer–synthetic polymer
hybrids (Table 4), protein–protein hybrids (Table 5), and synthetic
polymer–protein hybrids (Table 6) is given, and the available
mechanical data and the major outcomes of the research for each
material are shown.4.1. Synthetic polymer–synthetic polymer hybrid materials
Different polymers provide different characteristics. Whereas
some materials such as poly(lactic-co-glycolic acid) (PLGA) can
be easily degraded [132], other materials such as PGS have more
favorable mechanical functionalities like elasticity [9]. Often, acombination of these properties is necessary to obtain the desired
properties for tissue-engineered scaffolds.
Improving mechanical functionalities is a major reason for com-
bining polymers. For example, PLGA is a good candidate for tissue
engineering with high biocompatibility and biodegradable proper-
ties; however, this material can be quite brittle [133]. Therefore, a
copolymer of poly(glycolide-co-e-caprolactone) (PGCL) was syn-
thesized, and it showed a high increase in elastic behavior com-
pared to PLGA [133]. Some examinations of rat smooth muscle
cells cultured on PGCL showed adhesion of the cells after 3 days,
and seeded PGCL scaffolds implanted subcutaneously in mice
showed smooth muscle tissue formation in vivo [133]. Introduction
of e-caprolactone (CL) into poly(1,3-trimethylene carbonate)
(PTMC) resulted in a decrease in crystallinity of the scaffold com-
pared to PTMC [134], thus making poly(TMC-co-CL) a suitable scaf-
fold for nerve guidance. The human Schwann cells cultured on the
poly(TMC-co-CL) scaffold showed good adhesion and a prolifera-
tion rate similar to that of human Schwann cells cultured on gela-
tin, which was used as a positive control [135].
In another study, to obtain an elastic hydrogel, PEG crosslinks
were introduced between polyacrylamides (PAs) and poly(acrylic
acid) (PAA) [136]. The use of star-shaped PEG polymers with differ-
ent molecular weights as cross-linkers, instead of linear cross-
linkers, greatly improved the extensibility of the material to up
to 15000%. Cyclic tensile tests were performed with a maximum
strain of 400% [136]. Furthermore, the compression deformation
of these hydrogels could be performed to up to 98%, with a limited
deformation of the gel. To further analyze the feasibility of using
this hydrogel for tissue engineering applications, more studies
both in vitro and in vivo have to be performed. To influence the
mechanical properties of poly(glycerol adipate) (PGA), it was
copolymerized with ethylene glycol [137]. The amount of ethylene
glycol introduced led to a decrease in Young’s modulus and an
increase in the maximum deformation. Additionally, cell culture
studies showed that fibroblasts were differentiated into neuron-
like cells [137]. An elastomer was also created by introducing
either butadiene or ethylene-butadiene blocks into polystyrene
to form poly(styrene–butadienestyrene) (PSBS), known as a ther-
moplastic elastomer, and poly(styrene-ethylene-butadiene-styr
ene) (PSEBS) [138]. Introduction of the ethylene-butadiene seg-
ment led to better oxidative resistance and more elastic properties
than introduction of only butadiene. Both PSBS and PSEBS showed
declining hysteresis as the number of cycles increased. However, it
was shown that by changing the polymer backbone, the final
mechanical properties such as elasticity were influenced [138].
Combining mechanical properties with favorable degradation
behavior is vital for tissue engineering materials because the
degradation of the implanted scaffold allows for tissue ingrowth
and remodeling [139]. PCL exhibits elastic behavior but degrades
very slowly, whereas PLGA has a favorable degradation time but
is highly brittle on its own [140]. Combining PCL and PLGA into a
triblock copolymer therefore resulted in rapidly degradable poly-
mers with elasticity. The degradation time of PTMC, as a highly
elastic material, was also sped up by introducing PLA [134]. In
another study, copolymerizing TMC and L,D-lactic acid (LDLA) led
to amorphous elastomers with tunable degradation [141]. By using
a mole ratio of 20% TMC to 80% LDLA, a scaffold was designed for
cardiac tissue engineering application, which not only was flexible
and stable under physiological conditions but also allowed adhe-
sion and proliferation of cardiomyocytes [142].
To create a material with a slower degradation rate than PGCL,
CL was copolymerized with a different lactone, called lactic acid,
which resulted in the copolymer poly(L-lactide-co-e-
caprolactone) (PLCL). PLCL has gained particular interest for its
use in vascular tissue engineering owing to its high elasticity
[143,144]. Tubular PLCL scaffolds were prepared by an extrusion-
Table 4
List of available elastomeric hybrid scaffolds consisting of multiple synthetic polymers for tissue engineering applications (E = Young’s modulus).




E = 1900 MPa
Maximum strength = 51 MPa
Heart tissue
engineering
Suitable mechanical properties and
degradation behavior. In vitro studies





E = 5 MPa
Maximum strength = 2 MPa
Nerve guidance Suitable mechanical properties; promising
in vitro studies showed adhesion and
growth of human Schwann cells
PGCL [133] Recovery of 98% for strains up to
120%
Elongation at break = 250%
Vascular grafts Mechanical properties showed high
recovery; in vivo studies showed
formation of smooth muscle tissue
PLCL [144,191] Deformation at failure after 27 days
(10% amplitude and 1 Hz frequency)
= 10%
Vascular grafts Suitable mechanical functionality even for
long-term cyclic studies under in vivo
conditions. Good adhesion and
proliferation of smooth muscle cells
PLCL [145] Initial modulus = 9.34–24.6 MPa
Estimated compliance = 0.052–
0.0159 ml*mm/Hg
Vascular grafts Compliance in the region of natural
arteries; slow initial cell proliferation that
increased over time
PLCL [148] E = 0.37–0.73 MPa




The high recovery of the material after
loading indicates that the material can be
suitable for cartilage regeneration. In vitro
and in vivo studies showed chondrogenic
differentiation and mature cartilaginous
tissue formation
PGLCL [149] E = 90–140 Pa
Maximum strength = 14–38 kPa
– Mechanical properties similar to those of
PLCL and PGCL but with faster degradation
and more tunability
PCL-PDMS [152] E = 14–32 MPa




Shape memory polymer showing
proliferation of human fetal osteoblasts
in vitro as well as early bone matrix
formation
PLGA-PCL-PLGA [140] E = 20–26 MPa
Elongation at break = 400–480%
– Rapidly degradable and elastic polymer PLGA                     PCL 
PCL-PIBMD [153] at 25 C: E = 200 MPa
Elongation at break = 680%
at 75 C: E = 30 MPa




Shape memory material; in vitro testing
showed good cell viability and increased
cell activity
PIBMD,PCL
PSBS [138] E = 0.03–0.23 MPa
Elongation at break = 333–442%
– No cell toxicity was observed after 72 h
PSEBS [138] E = 9–38 MPa
Elongation at break = 585–1173%
– Higher elongation at break than PSBS, and
no cell toxicity was observed after 72 h
 
PEGS-AP [150] E = 15–25 MPa
Elongation at break = 50–1113%
Fatigue free in cyclic tensile tests




Conducting an elastomeric scaffold that
not only allowed proliferation of cells, but
also showed to promote cell
differentiation for C2C12 cells
PEGS, analine pentamer
PEG-PA or PAA [136] Elongation at break = 12,000–
15,000%
– Highly extensible hydrogel with sufficient
strength and good recovery
PEG                  PA             PAA
PGA-PEG [137] E = 0.07–1.18 MPa
Ultimate tension = 0.16–0.35 MPa




Ethylene glycol allowed for tunable
mechanical functionality. No cytotoxicity
and good adherence of cells; fibroblasts
showed differentiation toward neuron-
like cells
A.M.J. Coenen et al. / Acta Biomaterialia 79 (2018) 60–82 73particulate leaching technique and were characterized by cyclic
tensile strain tests in the culture media with amplitude and fre-
quency similar to those applied to vascular smooth muscle tissues
in vivo [144]. Tubular structures of the same material were also
fabricated by melt-spinning or electrospinning methods [145]. In
this study, a comparison between the mechanical properties ofthe obtained scaffolds and natural arteries revealed that peak
stress and strain values of the scaffolds were higher than those
of natural arteries, but the compliance had a magnitude same as
that of natural arteries. Cell proliferation on these scaffolds was ini-
tially slow but increased with progression of time [145]. Recently,
more changes were made in the production method, thus leading
Table 5
List of available elastomeric protein–protein hybrid scaffolds for tissue engineering applications (E = Young’s modulus).
Material Properties Application Major output
Elastin-collagen [154] E = 0.42–0.78 MPa
Tensile strength = 142–420 kPa
Tissue engineering In vitro tests with fibroblasts and myoblasts showed
positive results. However, no target tissue for the final
application has been defined
Elastin-collagen [155] E = 2.0–8.3 MPa
Yield stress = 0.06–0.26 MPa
Yield strain = 15–35%
Small-diameter blood vessel
regeneration
Cyclic tests have only been carried out on noncross-
linked material. In vitro studies with smooth muscle
cells for 14 days showed cells on both the surface and
inside of the 3D scaffolds
Tropoelastin-collagen [156] E = 166–841 kPa Dermal tissue engineering In vitro and in vivo studies showed fibroblast
proliferation, collagen synthesis, and blood vessel
formation within the scaffold




Different cell lines were tested for their compatibility; a
reduction in the activity of fibroblasts was observed but
no changes for endothelial and smooth muscle cells
were observed compared to those for collagen
Silk fibroin-elastin [158] – Wound dressing Wound healing studies showed increased keratinocyte
and fibroblast migration as well as coverage of the
wound with the new epithelium tissue
Silk-tropoelastin [159] E = 26–54 MPa
Elongation at break = 25–56%
Neuronal tissue engineering Increasing the tropoelastin amount in the scaffold
allowed for more adhesion of neurons to the surface
SELP [160] E = 1.67–3.34 MPa
Viscoelastic behavior up to 40%
strain
Resilience = 86–88%
– A material with elastic properties similar to those of the
native aortic elastin was obtained
Electrospun SELP [163] E = 142 MPa
Ultimate tensile
strength = 14 MPa
Strain to failure = 22%
Tissue engineering Good mechanical properties in combination with good
viability and proliferation of human skin fibroblasts
Table 6
List of available elastomeric synthetic polymer–protein hybrid scaffolds for tissue engineering applications (E = Young’s modulus).
Material Properties Application Major output Synthetic part of the structure
PEG-AKELP [164,165] E = 0.32 MPa (dry)/0.12 MPa
(hydrated)
Tissue engineering Indirect cytotoxicity tests
showed results same as
those of the control;
however, direct cell studies
showed low adhesion,
which was improved by
introducing an RGD motif
PEG-ELP [166] E = 2.5 kPa Tissue engineering Addition of PEG increased
the transition temperature
compared to pure ELP.
Additionally, it lowered the
E value. Cell studies showed
a cell viability of 98% after 4
and 7 days
PNPHO-elastin [167] Compression
modulus = 40–150 kPa
Injectable hydrogel Mostly focusing on tuning
the gelation temperature.
Cell viability was above 80%
when encapsulated
PLGA-elastin [168] E = 20.78 MPa Salivary epithelial cell
self-organization
Cross-linked PLGA fibers
connected to elastin. Lower
cell integration into the







modulus = 17–32 kPa
Mean peak stress at 10%
strain = 67–79 kPa
Mean peak stress at 40%




under 10% and 40% strain
Decrease in cell viability
after 3 weeks in the in vitro
tests with the disc
Hyaluronan, PEGDA
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burst pressure [146,147]. PLCL has also been investigated for carti-
lage tissue regeneration, and the formation of mature cartilage tis-
sue was shown in vivo [148]. To obtain a better control of the
degradation rate of PLCL-based scaffolds, the polymer was modi-
fied using two different lactones, thereby resulting in poly
(glycolide-co-L-lactide-co-e-caprolactone) (PGLCL) [149]. Although
mechanical properties and cell viability of PGLCL were similar to
those of PLCL and PGCL, the degradation rate increased [149].
To provide proper functionality to some tissue engineering scaf-
folds, a combination of more than two materials is needed. For
example, three different characteristics were combined in a
copolymer of PEG, PGS, and aniline pentapeptides (APs) [150].
Polyanilines are well-known polymers with tunable conductivity
that could be used to introduce an electrical stimulus, known to
have a positive effect on the development of functional cardiac
and skeletal muscle tissues. However, these materials are difficult
to process. To improve the mechanical functionality, elastic PGS is
used, but PGS is slowly degradable and has poor water uptake. It is
known that the copolymerization of PEG and PGS resulting in PEGSFig. 7. A) Schematic representation of the PEGS-AP chemical structure. B) An example of
weight percent on the differentiation of C2C12 cells. Reprinted from Dong et. al. [150] wleads to elastic hydrogels with tunable degradation [150]. Combin-
ing PEGS with AP and subsequent crosslinking with hexam-
ethylene diisocyanate (HDI) resulted in elastomeric and
conductive films (Fig. 7A). It was shown that increasing the AP con-
centration increased the elasticity of the scaffold. Cyclic tensile
tests, performed for 10 cycles, showed a large hysteresis for the
first loop (Fig. 7B). This is probably attributed to p-p interactions
between the AP fragments present before the first cycle, which
are not regained in the cyclic process. The cycles overlap after
the first one, thus leading to the inclination that a fatigue-free
material might have been obtained. These materials are particu-
larly useful for skeletal muscle tissue engineering because the con-
ducting polymers are shown to promote myogenic cell
differentiation of C2C12 cells (Fig. 7C) [150].
Shape memory materials are favorable in tissue engineering
because they allow for noninvasive implantation surgery owing
to the fact that they can be transplanted using small catheters.
Once implanted, they will expand and gain their final structure
[151]. To obtain an elastic material with the shape memory effect,
CL was copolymerized with dimethyl siloxane into PCL-cyclic tensile test results for a PEGS-AP film with 12 wt% AP. C) Influence of the AP
ith permission from ACS publications, copyright 2017.
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ratio between PCL and PDMS resulted in changes in the shape
behavior properties. In vitro studies with human fetal osteoblasts
showed good proliferation of the cells and an increase in the
expression of the ALP, a marker for osteogenic differentiation that
indicates the beginning of bone matrix deposition [152]. A differ-
ent type of shape memory scaffold was synthesized by copolymer-
izing PCL and poly(iso-butyl-morpholinedione) (PIBMD), a
polydepsipeptide [153]. Incorporation of polydepsipeptides is
thought to be advantageous for the degradation profile, whereas
block copolymers with PCL show elastic behavior. Combining these
two in a multiblock copolymer resulted in a shape memory mate-
rial interesting for soft tissue implants.
4.2. Protein–protein hybrids
As mimicking the ECM in terms of both structure and function
is a goal for tissue-engineered scaffolds, using natural ECM materi-
als is a logical step. Electrospun cross-linked elastin and collagen
scaffolds with different ratios were prepared [154]. By using
collagen-to-elastin ratios of 1:1 and 9:1, it was shown that an
increased ratio of elastin led to a reduction in both tensile strength
and Young’s modulus because the amine groups present were less
and the crosslinking density was lower. In vitro cytocompatibilityFig. 8. A) Electrospun scaffolds with different ratios of tropoelastin/collagen. B) Fibrobl
vessel formation after in vivo studies for 6 weeks for both the fabricated collagen-elasti
Kovacina et. al. [156], with permission from Elsevier, copyright 2012.tests carried out with fibroblasts showed good proliferation of
the cells on all scaffolds. It was also shown that myoblasts aligned
and adhered to form myotubes in both 9:1 and 1:1 ratios of colla-
gen to elastin scaffolds; however, on the 1:9 ratio of collagen to
elastin scaffolds, the cells showed only round structures. Prolifera-
tion of the cells on the elastin-rich scaffolds was lower and thus
limited the interactions between the cells, which is needed for dif-
ferentiation. Cross-linked scaffolds of elastin and collagen were
prepared for small-diameter blood vessel regeneration [155].
Introducing the crosslinks led to an increase in the stiffness of
the scaffold compared to the non-cross-linked matrices, and
in vitro cell studies on the cross-linked scaffolds showed expansion
of smooth muscle cells during a 14-day culture period.
Precursors of native elastin and elastin derivatives have been
used in combination with collagen for scaffold fabrication
(Fig. 8A). Electrospun scaffolds of tropoelastin cross-linked with
glutaraldehyde were analyzed by tensile testing in PBS at 37 C
(Fig. 8A) [156]. These tests showed that 50% or more collagen
needed to be present compared to tropoelastin to provide the
required mechanical properties. This is in line with the findings
that small amounts of elastin can have a significant influence on
the mechanical properties, as discussed in Section 2.3. For instance,
the amount of elastin in the skin is approximately 2% of the tissue
dry weight, but this amount has a significant impact on the elastic-ast migration on two different scaffolds during in vitro studies for 8 days. C) Blood
n scaffold (left) and the commercial Integra scaffold (right). Reprinted from Rnjak-
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both collagen and elastin plays a crucial role with regard to this,
meaning that only a small amount of elastin does not necessarily
provide the proper elasticity that a tissue requires. Both in vitro
and in vivo tests showed good mechanical integrity of the scaffold
up to 6 weeks after subcutaneous implantation. In addition, fibrob-
last infiltration (Fig. 8B), deposition of new collagen matrix, and
vascularization (Fig. 8C) within the newly formed tissue were
observed [156]. In a different study, collagen was cross-linked
using ELPs [157]. Although only a limited amount of data can be
found on the mechanical properties of these scaffolds, it was indi-
cated that the shear modulus increased relative to the concentra-
tion of the ELP, and in vitro tests showed reduced metabolic
activity of fibroblasts compared to those cultured on pure collagen
scaffolds. However, no difference in metabolic activity between
endothelial cells and smooth muscle cells was found [157].
Elastin and elastin-like materials are often combined with silk
fibroin or silk derivatives to form silk–elastin or silk–elastin-like
polypeptides (SELPs). One example is the cross-linked silk
fibroin–elastin scaffold [158], from which no mechanical charac-
terization is available. However, the scaffolds showed high cell via-
bility, and the presence of elastin increased the cell proliferation.
Wound healing tests of the silk fibroin–elastin scaffold were car-
ried out and compared with commercially available collagen dress-
ings, and the results showed that scaffolds with a higher amount of
elastin were able to induce keratinocyte and fibroblast migration
[158]. Furthermore, the wounds were covered with a new layer
of epithelium after 6 days of healing [158]. In another study, pri-
mary cortical neuron viability rates were used to study the feasibil-
ity of silk–tropoelastin scaffolds for neural tissue engineering
[159]. Increasing the amount of tropoelastin improved the adhe-
sion of the cells to the scaffold. However, using a scaffold with a
high percentage of tropoelastin (50% or more) led to a high per-
centage of cell death, probably owing to the high positive net
charge of the surface [159].
Moreover, silk derivatives were combined with the ELP using
recombinant techniques to fabricate SELPs. These SELPs showed
elasticity similar to that of the native elastin [160]. In addition,
these SELPs were able to self-assemble into nanofibers [161,162].
Electrospun SELPs showed good mechanical properties, and
in vitro cell viability and proliferation showed that SELPs could
be a promising material for tissue engineering applications [163].
4.3. Synthetic polymer–protein scaffolds
As discussed in the previous sections, both synthetic and
protein-based materials have their own advantages and disadvan-
tages. To make use of all advantages, synthetic and protein-based
materials can be combined into hybrid polymer–protein scaffolds.
For example, to obtain an elastic scaffold, a block-co-polymer
between PEG and a mimic of the hydrophilic-, alanine-, and
lysine-rich parts of tropoelastin (AKELP) was made [164]. This
PEG-AKELP showed compliant behavior until a strain of 10–15%
under cyclic compression, after which stiffening occurred. The
stress–strain curves overlapped by increasing the number of cycles
and thus proved the elasticity of the scaffold. Cytotoxicity of PEG-
AKELP was tested through indirect contact with porcine vocal cord
fibroblasts, which showed no significant difference compared to
the control. However, when direct cell studies were performed,
good adhesion was not observed. In a later study, cell adhesion
was improved by introducing an RGD motif onto the AKELP
[165], which also influenced the mechanical properties.
PEG was introduced into an ELP scaffold to improve its trans-
parency for 3D imaging [166]. However, it also influenced the func-
tionalities of the scaffold. The presence of PEG increased the
transition temperature of the LCST behavior but lowered the elasticmodulus to 2.5 kPa compared to 5.6 kPa for a pure ELP hydrogel.
Encapsulation studies of human fibroblasts into the ELP-PEG hydro-
gel showed 98% viability after both 4 and 7 days of culture [166]. To
finely tune the mechanical properties of a complex water-soluble
copolymer, containing poly(N-isopropylacrylamide) (PNIPAAm),
polylactide-2-hydroxyethyl methacrylate (PLA-HEMA) and oligo
(ethylene glycol) monomethyl (OEGMA), called PNPHO, was com-
binedwith elastin in different ratios [167]. Enhanced hydrophilicity
by increasing the OEGMA ratio led to an increase in the gelling tem-
perature, whereas an increased amount of the hydrophobic part
(PLA-HEMA) led to a decrease in the gelling temperature. Finally,
the gelling temperature could be tuned between 11 C and 40 C.
The compression moduli of these hydrogels were between 40 and
150 kPa. Cell culture studies on the hydrogels showed cell viability
of more than 80% immediately after cell encapsulation and showed
good proliferation of cells after 5 days.
PLGA hybrids with elastin were also investigated for tissue
engineering applications [168]. An increase in Young’s modulus
was found unexpectedly for the covalently linked PLGA-elastin. It
was proven, however, that the change could be explained by the
crosslinking of the PLGA fibers. The coupling reagents (1-ethyl-3-
(3-dimethylaminopropyl, N-hydroxysuccinimide, and ethanesul-
fonic acid) used to covalently link PLGA to elastin are known to also
crosslink PLGA. Thus, treating the PLGA with the same chemicals
without the presence of elastin led to an increase in Young’s mod-
ulus to 20.4 MPa, thus proving that the increase in Young’s modu-
lus is mainly due to the crosslinking of the PLGA. The differences in
the 3D structure between the blended elastin-PLGA scaffold and
the covalently linked PLGA-elastin are due to not only the covalent
link between PLGA and elastin but also crosslinking; these materi-
als were still compared in cell culture studies. Therefore, the influ-
ence of the covalent bond between elastin and PLGA and the
influence of the crosslinking on the results of these cell studies
remain unclear [168].
A hybrid material of thiol-functionalized hyaluronan and elastin
prepared by using poly(ethylene glycol) diacrylate (PEGDA) as a
crosslinker was assessed as a possible replacement for the nucleus
pulposus of the intervertebral disc [169]. Although mechanical
properties of these hydrogels were tunable, in vivo tests did not
lead to a significant improvement in the patients [169]. As combin-
ing proteins and polymers through covalent bonds for tissue engi-
neering has been recently started, many possibilities could still be
investigated regarding the mechanical functionality and biological
compatibility to obtain a complete picture of the potential of these
materials for tissue engineering applications.5. Discussion
The previous section provided an overview of different possibil-
ities to introduce elasticity into tissue-engineered scaffolds with
emphasis on the mechanical performance as well as the biological
compatibility both in vitro and in vivo. All protein-based, synthetic,
and hybrid materials exhibit interesting mechanical and biomedi-
cal functionalities, each with its own advantages and disadvan-
tages (Table 7), thereby allowing for a fine-tuned solution for
each application. The possibilities can be further extended by
introducing biologically active components such as cell-
penetrating motifs like RGD peptides [170–172]. Furthermore, dif-
ferent biological molecules could be combined with synthetic poly-
mers such as a combination between submucosa and PU to obtain
a scaffold for soft tissue engineering [173] or a combination
between poly(isocyanopeptides) and DNA resulting in a hydrogel
with properties tunable by external stimuli [174].
It is often difficult to compare the properties of different scaf-
folds. Mechanical analysis of the scaffolds is not always available,
Table 7
Advantages and disadvantages of different material categories for tissue engineering applications.
Material Advantages Disadvantages
Decellularized tissues - Close mimic of the ECM structure of the native tissue [192] - Limited applications owing to limits in the size and the shape
[22]
- Thorough purification is required, which needs optimization
for each different tissue [193]
Purified insoluble elastin - Biocompatible
- Natural material [60]
- Purification often compromises functionality
- Difficult to process [22]
Purified soluble elastin - Biocompatible
- Improved processability compared to insoluble elastin
- Large badge-to-badge variation




ELP - Tunability of the construct
- Biocompatible
- Short shelf-life
- Thermal instability [194]
Synthetic elastomers - Tunable mechanical properties
- Size and shape can be varied.
- Lacking biological activity
- Often, either good mechanical properties or preferable
degradation
Polymer–polymer hybrids - Combining the advantages of different synthetic polymers
- Highly tunable
- Often lacking biological activity
Protein–protein hybrids - Higher tunability of mechanical functionalities compared to
single protein-based materials
- Thermal instability
- Obtaining the components might be challenging
Polymer–protein hybrids - Both biological and mechanical functionality present in the
same material
- Highly tunable mechanical functionality
- Synthesis might be challenging
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under different conditions. As explained in Section 2.2, elastin
has a different mechanical behavior under wet conditions com-
pared to dry conditions; the same would also probably apply to
materials based on elastin. The Young’s modulus of materials is
not directly comparable because it is influenced by either the tem-
perature, humidity, rate of the strain, relaxation time, or the type of
the experiment. Furthermore, although Young’s modulus gives an
indication of elasticity, it is not sufficient to make conclusions for
elasticity under noncyclic large strains. To prove this, cyclic
stress–strain tests are of vital importance to provide a real indica-
tion of macroelastic behavior. However, some scaffolds with
potential mechanical functionality for tissue engineering applica-
tions have yet to be evaluated using in vitro or in vivo studies to
prove their biological compatibility for different targets.
Different measurement methods and different circumstances
under which the measurements are carried out clearly lead to
incomparability of the results. This becomes an issue when com-
paring different materials for a specific tissue engineering applica-
tion. Therefore, it is crucial to set guidelines for each tissue
engineering application with regard to the type of tests that need
to be carried out. These tests should be performed under measure-
ment circumstances that are comparable to the in vivo environ-
ment. The tests should cover both mechanical and biological
evaluations, which will then lead to more cohesion and better
comparability of the results.
In this review, introducing elastic components to the scaffolds is
discussed. However, there are studies on how elastin production
by cells and thus elasticity of the tissue-engineered constructs
can be enhanced [11]. It has been shown that polyphenols
increased the deposition of elastin by smooth muscle cells by
enhancing the coacervation of tropoelastin; increasing lysyl oxi-
dase synthesis, a crosslinking component; and inhibiting matrix
metalloproteinase-2 activity that degrades elastin [175]. The addi-
tion of hyaluronan in combination with copper ions or transform-
ing growth factor-b shows an increase in elastin production in
adult rat smooth muscle cells [11,176]. In addition, heparin
increased the elastin production in adult smooth muscle cells
and fibroblasts as well as fetal cells [177].
Mechanical stimulation of tissue-engineered constructs also led
to the increased elastin production [178–180]. However, thesemethods led to the presence of immature elastin, which does not
result in the formation of an elastic matrix and is more prone to
degradation by metalloproteinases and cathepsin S [181,182].
Moreover, the degradation products of immature elastin can cause
calcification [183] and induce transformation of cell phenotypes,
for example, from vascular smooth muscle cells to osteoblast-like
cells [184]. It has been reported that fragments of elastin had an
impact on inflammatory cells. For instance, elastin-derived pep-
tides induced T-helper type 1 polarization of human blood lym-
phocytes [185]. Therefore, these shortcomings need to be
considered when immature elastin is being introduced to the con-
structs in vitro or in situ.
It is important to note that for an implant to have long-term
in vivo functionality, it should not only be mechanically and biolog-
ically functional upon implantation but also keep its function with
time by maintaining a balance between the degradation rate of the
scaffold and the formation of the neotissue. If the rate of the mate-
rial degradation is significantly lower than the rate of the neotissue
formation, it will result in calcification and fibrotic tissue forma-
tion at the implant site. However, if the material degradation is
much faster than the neotissue formation, mechanical stability of
the implant will be hampered [186]. Another important parameter
to be addressed in the future studies is the spatial distribution of
elastin. In many types of tissue, the amount and the structure of
elastin differ spatially. This will lead to a tissue with heterogeneous
mechanical properties, which is crucial for its proper in vivo func-
tionality and thus has to be considered when designing the
scaffolds.
Finally, smart materials are gaining interest for tissue engineer-
ing applications. For example, a wound dressing that could react to
the environment by changing the permeability of the scaffold
based on the moisture level of the wound was developed [187].
This self-changing ability could greatly increase the healing ability
of the tissue. A shock-absorbent self-healing injectable scaffold
was also synthesized to be used as an artificial nucleus pulposus
of the intervertebral disc to improve the mechanical properties
after implantation compared to nonhealing materials [188]. Com-
bining these smart material functionalities with elastic materials
could be the next step within the elastic tissue engineering field.
In conclusion, a combination of mechanical functionality,
biological activity, and biocompatibility of the tissue-engineered
A.M.J. Coenen et al. / Acta Biomaterialia 79 (2018) 60–82 79scaffold is of great importance for the translation of these methods
into the clinic. Furthermore, these scaffolds should be able to main-
tain these mechanical and biological functions to provide long-term
durability. To improve comparability of the different constructs,
defining standard guidelines with regard to the measurement meth-
ods and conditions is necessary. Overall, the ability to introduce
elasticity into the scaffolds increases the range of mechanical func-
tionalities that can be fabricated and thus increases the potential
applications for which the material can be used.Acknowledgments
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